C4X Discovery brings a new dimension to drug discovery. Using its unique NMR-based technique to determine 3D molecular structures with high accuracy, C4X Discovery is focused on optimising the design and development of medicines and partnering with the pharmaceutical sector to generate better, safer products. C4X Discovery is able to determine the bioactive 3D structures of a variety of biologically important molecules, including drugs, naturally occurring ligands and enzyme co-factors, and does this independently of traditional methods such as computational modelling and X-ray crystallography. C4X Discovery is applying its unique technology to improve the efficiency of the drug discovery process, both in partnership with the pharmaceutical industry and across its own pipeline of high-value therapeutic targets.
Manchester, GB
Size (employees)
19 (est)
C4X Discovery was founded in 2007 and is headquartered in Manchester, GB
Report incorrect company information

C4X Discovery Office Locations

C4X Discovery has an office in Manchester
Manchester, GB (HQ)
Manchester One 53 Portland St
Show all (1)
Report incorrect company information

C4X Discovery Financials and Metrics

C4X Discovery Financials

C4X Discovery's revenue was reported to be £143 k in FY, 2017

Revenue (FY, 2017)

143 k

Gross profit (FY, 2017)

140 k

Gross profit margin (FY, 2017), %


Net income (FY, 2017)

(6.8 m)

EBITDA (FY, 2017)

(8.3 m)

EBIT (FY, 2017)

(8.5 m)

Market capitalization (31-Oct-2017)

29.4 m

Closing share price (31-Oct-2017)


Cash (31-Jul-2017)

6 m
C4X Discovery's current market capitalization is £29.4 m.
GBPFY, 2014FY, 2015FY, 2016FY, 2017


619 k312 k279 k143 k

Revenue growth, %


Cost of goods sold

23 k112 k12 k3 k

Gross profit

596 k200 k267 k140 k
GBPFY, 2014FY, 2015FY, 2016FY, 2017


673 k3.5 m1.3 m6 m

Accounts Receivable

15 k31 k39 k85 k

Current Assets

1.1 m8.6 m3.2 m8.3 m


21 k85 k94 k90 k
GBPFY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(1.1 m)(3.1 m)(5.3 m)(6.8 m)

Cash From Operating Activities

(834 k)(3.2 m)(6 m)(6.6 m)

Cash From Financing Activities

10.1 m

Net Change in Cash

(841 k)2.8 m(2.2 m)4.7 m
GBPY, 2017


7.5 k

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information